Doximity (DOCS) Research & Development (2020 - 2026)

Doximity (DOCS) has 7 years of Research & Development data on file, last reported at $39.1 million in Q1 2026.

• Research & Development for Q1 2026 came in at $39.1 million, up 57.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $130.7 million (up 40.48% YoY), and the FY2026 annual result was $130.7 million, up 40.48% from the prior year.
• Research & Development climbed to $39.1 million in Q1 2026 per DOCS's latest filing, from $34.6 million in the prior quarter.
• Over five years, Research & Development peaked at $39.1 million in Q1 2026 and troughed at $17.4 million in Q1 2022.
• A 5-year average of $23.7 million and a median of $21.9 million in 2023 frame the typical range for Research & Development.
• The sharpest annual moves came in 2024 and 2026: Research & Development decreased 6.47% in 2024, then soared 57.67% in 2026.
• A 5-year view of Research & Development shows it stood at $20.5 million in 2022, then fell by 2.79% to $19.9 million in 2023, then rose by 12.41% to $22.4 million in 2024, then soared by 54.3% to $34.6 million in 2025, then grew by 13.04% to $39.1 million in 2026.
• Business Quant data shows DOCS's Research & Development at $39.1 million in Q1 2026, $34.6 million in Q4 2025, and $30.2 million in Q3 2025.